Lifeward Limited Reports Q3 Loss, Projects $24-26M Revenue
Update: 2025-11-14
Description
Lifeward Limited, a pioneer in wearable robotic exoskeletons, reported a Q3 net loss of $3.2M, or $0.20 per share, despite generating $6.2M in revenue from medical device sales. The company projects full-year revenue between $24M-$26M, signaling continued operations in the medical technology sector.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
